Sabre (SABR): Constellation’s most asymmetric bet
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
@yenoms One of us! One of us!! $VNO Pref Gang
Dear $AMC Apes. Your favorite stock is cheaper than last week. Maybe it is time to buy more.
Knife River expects FY26 EBITDA margin to fall 138 basis points as project delays and fuel costs bite, while Sharper EDGE targets…
India’s 236 GWh battery target boosts local electrolyte-salt makers, while Mirion’s radiation monitors and Overwatch’s passive drone…
Remitly’s Q3 revenue growth accelerated to 22% as lower transaction losses lifted margins, while recipient-facing products build a…
Chord Energy trades at 3x mid-cycle EV/EBITDA with a 15% free-cash-flow yield at $75 WTI, while repurchasing shares and expanding its…
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward…
Century Aluminum (CENX) could benefit from U.S. tariffs, Midwest aluminum premiums and constrained global supply, with the stock trading…
Figma grew Q3 revenue 43% to $391.4 million, raised FY2026 guidance to nearly $1.5 billion and guided Q4 above consensus despite the stock…
Perpetua Resources’ permitted Stibnite project holds 4.8 million gold ounces and a $2.9 billion EXIM loan, but faces single-asset…
Monte Investments rotated Nvidia into Alphabet before earnings and reviews Knife River’s margin squeeze, AMD’s World Labs acquisition, and…
Forestar trades near $22 versus $37.56 in tangible book value, with $657 million of cash and a potential D.R.
MONOY · long MonotaRO, traded as MONOY in the U.S. and 3064 in Japan, is a Japanese MRO distributor recommended as a long.
TransMedics reported record Q3 2026 revenue exceeding $200 million, driven by its organ transplant technology business.
Wolfspeed's negative Q1 margins and revenue decline have not changed the bullish case for silicon-carbide power devices in data centers.
Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…
Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…
AutoNation, Lear, NexPoint, AudioCodes and Xponential Fitness lead a 52-situation screen spanning buybacks, insider purchases, M&A and…
Array Technologies and Shoals Technologies plan to merge, targeting cross-selling and cost synergies as ARRY's order book holds firm and…
Empire State Realty Trust repurchased $85.8 million of shares at $4.56 each, using 1359 Broadway sale proceeds to fund buybacks and debt…
Warrior Met Coal’s Blue Creek mine cut costs to about $93 a ton, offsetting a wider discount for High Vol A coking coal as US supply…
AMSC and Datadog will be fine, while SiTime is worth a closer look.
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.